|
|
Volumn 57, Issue 3, 2010, Pages 534-537
|
|
The Motion: GnRH Antagonists are the New Way Forward in Hormonal Therapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABARELIX;
ANTIANDROGEN;
CITRALIX;
DEGARELIX;
GONADORELIN;
GONADORELIN AGONIST;
GONADORELIN ANTAGONIST;
GOSERELIN;
LEUPRORELIN;
TESTOSTERONE;
UNCLASSIFIED DRUG;
ARTICLE;
CLINICAL TRIAL;
DRUG COST;
HORMONAL THERAPY;
HUMAN;
MONOTHERAPY;
PRIORITY JOURNAL;
PROSTATE CANCER;
TESTOSTERONE BLOOD LEVEL;
BLOOD;
DRUG ANTAGONISM;
MALE;
PROSTATE TUMOR;
GONADOTROPIN-RELEASING HORMONE;
HUMANS;
MALE;
PROSTATIC NEOPLASMS;
TESTOSTERONE;
|
|
EID: 74649086039
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: 10.1016/j.eururo.2009.11.040 Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|
